[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100580830":3},{"organization":4,"outcomesModule":7,"designInfo":18,"detailedDescription":11,"studyPopulation":21,"armGroups":22,"interventions":11,"overallOfficials":11,"centralContacts":26,"locations":32,"responsibleParty":51,"collaborators":53,"id":57,"slug":11,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":66,"maxAge":11,"enrollmentInfo":67,"targetDuration":11,"studyType":70,"phases":11,"briefSummary":71,"conditions":72,"keywords":11,"overallStatus":35,"whyStopped":11,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Checkmab S.r.l.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":15,"otherOutcomes":11},[9,13],{"measure":10,"description":11,"timeFrame":12},"Validation of molecular targets for immunotherapy",null,"04.2023-06.2026",{"measure":14,"description":11,"timeFrame":12},"Selection of therapeutic antibodies",[16],{"measure":17,"description":11,"timeFrame":12},"Set up of immunological assays to adress monoclonal antibodies mechanism of action",{"allocation":11,"interventionModel":11,"interventionModelDescription":11,"primaryPurpose":11,"observationalModel":19,"timePerspective":20,"maskingInfo":11},"COHORT","PROSPECTIVE","Healthy subjects",[23],{"label":24,"type":11,"description":25,"interventionNames":11},"Healthy Donors","subjects over 18 years of age",[27],{"name":28,"role":29,"phone":30,"phoneExt":11,"email":31},"Renata M Grifantini, PhD","CONTACT","0039 00660220","renata.grifantini@checkmab.eu",[33],{"facility":34,"status":35,"city":36,"state":11,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"S.C. Medicina Trasfusionale - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","RECRUITING","Milan","20122","Italy","IT",{"type":41,"coordinates":42},"Point",[43,44],9.18951,45.46427,{"lat":44,"lon":43},[47],{"name":48,"role":29,"phone":49,"phoneExt":11,"email":50},"Daniele Prati, MD","0039 0255034687","daniele.prati@policlinico.mi.it",{"type":52,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[54],{"name":55,"class":56},"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","OTHER","100580830",false,"NCT06842407","Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)","Nuovi Bersagli Per lo Sviluppo di Anticorpi Monoclonali Per Immunoterapia - (Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)","Immuno-ab","Inclusion Criteria:\n\n* blood donors\n* age of 18 years or more\n* able to sign informed consent\n\nExclusion Criteria:\n\n* age below 18 years\n* Positive for HIV, HCV, HBV\n* not suitable for blood donation\n* not able to understand or sign informed consent",true,"ALL","18 Years",{"count":68,"type":69},600,"ESTIMATED","OBSERVATIONAL","The first objective of the project consists in the preclinical validation of new possible molecular targets associated with intratumoral T regulatory cells. The second objective consists in the selection of monoclonal antibodies with therapeutic potential, specific for the selected targets.",[24],"2025-02-19",{"date":75,"type":76},"2025-02-24","ACTUAL",{"date":78,"type":76},"2023-04-01",{"date":80,"type":69},"2026-06-30",{"name":5,"class":6},1]